Sharda Narayan Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 07-11-2024
- Paid Up Capital ₹ 1.50 M
as on 07-11-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -6.70%
(FY 2023)
- Profit 21.60%
(FY 2023)
- Ebitda 6.17%
(FY 2023)
- Net Worth 95.71%
(FY 2023)
- Total Assets 49.46%
(FY 2023)
About Sharda Narayan Pharmacy
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Singh and Ekika Singh serve as directors at the Company.
- CIN/LLPIN
U24304UP2020PTC133797
- Company No.
133797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Azamgarh, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sharda Narayan Pharmacy?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Singh  | Director | 02-Sep-2020 | Current |
| Ekika Singh | Director | 02-Sep-2020 | Current |
Financial Performance of Sharda Narayan Pharmacy.
Sharda Narayan Pharmacy Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.7% decrease. The company also saw a substantial improvement in profitability, with a 21.6% increase in profit. The company's net worth Soared by an impressive increase of 95.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sharda Narayan Pharmacy?
In 2023, Sharda Narayan Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sharda Narayan Health Care Private LimitedActive 17 years 1 daySanjay Singh and Ekika Singh are mutual person
Nutribiosciences Private LimitedActive 4 years 1 monthSanjay Singh and Ekika Singh are mutual person
- Sharda Narayan Mediclinic Private LimitedActive 3 years 7 months
Sanjay Singh and Ekika Singh are mutual person
- Maunath Bhanjan Cricket AssociationActive 2 years 6 months
Sanjay Singh and Ekika Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sharda Narayan Pharmacy?
Sharda Narayan Pharmacy has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sharda Narayan Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sharda Narayan Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
